Phase 2a Evaluation of PLN-74809 on ?v?6 Receptor Occupancy Using PET Imaging in Participants With IPF/
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- 18
Summary
- Conditions
- Idiopathic Pulmonary Fibrosis
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: Non-RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: Open label, up to 2 single doses administered at two different timesMasking: None (Open Label)Masking Description: No maskingPrimary Purpose: Treatment
Participation Requirements
- Age
- Between 40 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04072315
- Collaborators
- Stanford University
- Investigators
- Study Director: Pliant Therapeutics Medical Monitor Pliant Therapeutics, Inc.
Get Well Soon